To view the fulltext, please log in
To view the pdf, please log in
The Amsterdam drug policy is based on prevention, drug-free treatment and harm reduction interventions. This article focusses on the last aspect. Harm reduction is defined as ‘If a drug user is not capable or willing to give up his drug use, he should be assisted in reducing the harm caused to himself and others.’ Two harm reduction interventions are described: the needle exchange schemes and the provision of methadone (low-threshold clinics, methadone bus, police stations and through general practitioners). Besides general indicators, such as estimated number of heroin addicts and their average age, results of more specific evaluation projects are discussed to examine the effects of harm reduction interventions. It is concluded that the policy was effective in managing the drug problem (stable number of addicts, low number of new young drug addicts, low mortality rate), but that effective measures against the HIV epidemic were taken too late. Furthermore, harm reduction interventions have not discouraged drug users from making use of drug-free treatment facilities.
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.